Status:

COMPLETED

Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus

Lead Sponsor:

Alcon Research

Conditions:

Cataract

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to determine the safety and efficacy of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS Plus for use during cataract extraction and intra-ocular len...

Eligibility Criteria

Inclusion

  • Patients any race or sex 18 or older and undergoing cataract extraction with planned implantation of a posterior chamber intraocular lens.
  • Other protocol-defined inclusion criteria may apply.

Exclusion

  • Under 18
  • Other protocol-defined exclusion criteria may apply.

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2005

Estimated Enrollment :

369 Patients enrolled

Trial Details

Trial ID

NCT00333268

Start Date

September 1 2004

End Date

July 1 2005

Last Update

March 5 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

United States

Fort Worth, Texas, United States, 76134